National trends in stroke after acute myocardial infarction among Medicare patients in the United States: 1999 to 2010.

[1]  T. Jernberg,et al.  The risk of ischemic stroke after an acute myocardial infarction in diabetic subjects , 2013 .

[2]  L. Goldstein,et al.  30-Day Risk-Standardized Mortality and Readmission Rates After Ischemic Stroke in Critical Access Hospitals , 2012, Stroke.

[3]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[4]  D. Tanné,et al.  Trends in Management and Outcome of Hospitalized Patients With Acute Stroke and Transient Ischemic Attack: The National Acute Stroke Israeli (NASIS) Registry , 2012, Stroke.

[5]  M. J. Hall,et al.  Hospitalization for stroke in U.S. hospitals, 1989-2009. , 2012, NCHS data brief.

[6]  M. Mitka.  Heart disease and stroke deaths fall, but some fear a reverse in the trend. , 2012, JAMA.

[7]  L. Goldstein,et al.  30-Day Mortality and Readmission After Hemorrhagic Stroke Among Medicare Beneficiaries in Joint Commission Primary Stroke Center-Certified and Noncertified Hospitals , 2011, Stroke.

[8]  L. Goldstein,et al.  Outcomes after ischemic stroke for hospitals with and without Joint Commission–certified primary stroke centers , 2011, Neurology.

[9]  Daniel Polsky,et al.  Coronary revascularization trends in the United States, 2001-2008. , 2011, JAMA.

[10]  Harlan M. Krumholz,et al.  An Administrative Claims Model for Profiling Hospital 30-Day Mortality Rates for Pneumonia Patients , 2011, PloS one.

[11]  Harlan M Krumholz,et al.  Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. , 2011, Journal of hospital medicine.

[12]  Harlan M. Krumholz,et al.  An Administrative Claims Measure Suitable for Profiling Hospital Performance Based on 30-Day All-Cause Readmission Rates Among Patients With Acute Myocardial Infarction , 2011, Circulation. Cardiovascular quality and outcomes.

[13]  Rashmi Sinha,et al.  Trends in meat consumption in the USA , 2010, Public Health Nutrition.

[14]  L. Newby,et al.  Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry. , 2010, American heart journal.

[15]  R. Hanson,et al.  Secular Trends in Treatment and Control of Type 2 Diabetes in an American Indian Population: A 30-Year Longitudinal Study , 2010, Diabetes Care.

[16]  D. Gladstone,et al.  Anticoagulation after Anterior Myocardial Infarction and the Risk of Stroke , 2010, PloS one.

[17]  S. Normand,et al.  Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries: Progress and Continuing Challenges , 2010, Circulation.

[18]  S. Normand,et al.  Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. , 2009, JAMA.

[19]  Michael Weis,et al.  Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. , 2008, European heart journal.

[20]  K. Reynolds,et al.  Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines , 2008, The Annals of pharmacotherapy.

[21]  Sharon-Lise T. Normand,et al.  An Administrative Claims Measure Suitable for Profiling Hospital Performance on the Basis of 30-Day All-Cause Readmission Rates Among Patients With Heart Failure , 2008, Circulation. Cardiovascular quality and outcomes.

[22]  J. Avorn,et al.  Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. , 2008, Journal of the American College of Cardiology.

[23]  Christopher E. Buller,et al.  2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2008, Circulation.

[24]  H. Gurm,et al.  Recent trends in hospital utilization for acute myocardial infarction and coronary revascularization in the United States. , 2007, The American journal of cardiology.

[25]  L. Kozak,et al.  Use and in-hospital mortality associated with two cardiac procedures, by sex and age: national trends, 1990-2004. , 2007, Health affairs.

[26]  G. Lamas,et al.  Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2007 .

[27]  S. Normand,et al.  An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With an Acute Myocardial Infarction , 2006, Circulation.

[28]  Harlan M Krumholz,et al.  An Administrative Claims Model Suitable for Profiling Hospital Performance Based on 30-Day Mortality Rates Among Patients With Heart Failure , 2006, Circulation.

[29]  V. Roger,et al.  The incidence of stroke after myocardial infarction: a meta-analysis. , 2006, The American journal of medicine.

[30]  B. Yawn,et al.  A Community-Based Study of Stroke Incidence after Myocardial Infarction , 2005, Annals of Internal Medicine.

[31]  D. Levy,et al.  Recent trends in smoking and the role of public policies: results from the SimSmoke tobacco control policy simulation model. , 2005, Addiction.

[32]  G. Lamas,et al.  ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.

[33]  W. Aronow,et al.  Comparison of frequency of left ventricular thrombi in patients with anterior wall versus non-anterior wall acute myocardial infarction treated with antithrombotic and antiplatelet therapy with or without coronary revascularization. , 2004, The American journal of cardiology.

[34]  Lisa I. Iezzoni,et al.  Risk Adjustment of Medicare Capitation Payments Using the CMS-HCC Model , 2004, Health care financing review.

[35]  H. Arnesen,et al.  Warfarin, aspirin, or both after myocardial infarction. , 2002, The New England journal of medicine.

[36]  H. Krumholz,et al.  Risk and Predictors of Stroke After Myocardial Infarction Among the Elderly: Results From the Cooperative Cardiovascular Project , 2002, Circulation.

[37]  P. Whelton,et al.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. , 1998, JAMA.

[38]  G. Lamas,et al.  Ventricular dysfunction and the risk of stroke after myocardial infarction. , 1997, The New England journal of medicine.

[39]  J. Lichtman,et al.  In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis , 1994, Neurology.

[40]  P Smith,et al.  The effect of warfarin on mortality and reinfarction after myocardial infarction. , 1990, The New England journal of medicine.

[41]  L. Bolognese,et al.  RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.

[42]  Sarah Parish,et al.  Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.

[43]  E. Veys,et al.  HL-A AND INFECTIVE SACROILEITIS , 1974 .